Morgan Stanley Remains Overweight On Rockwell Collins

Morgan Stanley is out with a research report on Rockwell Collins ROC and is cutting its earnings estimates, but is remaining Overweight with a $72 price target on shares. In a note to clients, Morgan Stanley writes, "FY3Q was a tale of two end-markets for COL. Improving aero backdrop & better results on the commercial systems was overshadowed by a miss on the gov't side thanks to defense budget delays w/ the Continuing Resolution. Now that expectations have been reset, COL could outperform should fears of further cuts not come to fruition and/or mgmt releases a more upbeat FY12 guidance in Sept, guiding near/close to our $4.50e." Shares of ROC gained 46 cents on Friday to close at $61.12.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsMaterialsMorgan StanleySpecialty Chemicals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!